Title	Publication Date	Language	Citations
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine	2007/06/01	English	297
Provider communication and HPV vaccination: The impact of recommendation quality	2016/02/01	English	294
Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases	2006/08/01	English	290
Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data	2007/08/01	English	289
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis	2009/06/01	English	286
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin	2008/01/01	English	285
Vaccine hesitancy	2015/11/01	English	284
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18	2006/07/01	English	283
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses	2006/08/01	English	279
Validity and reliability of a survey to identify vaccine-hesitant parents	2011/09/01	English	279
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials	2019/05/01	English	278
Vaccine hesitancy among healthcare workers in Europe: A qualitative study	2016/09/01	English	278
Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease	2006/08/01	English	276
Factors underlying parental decisions about combination childhood vaccinations including MMR: A systematic review	2010/06/01	English	275
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens	2012/05/01	English	274
Economic burden of seasonal influenza in the United States	2018/06/01	English	272
The global impact of vaccination against hepatitis B: A historical overview	2008/11/01	English	268
Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology	2009/06/01	English	267
The vaccine hesitancy scale: Psychometric properties and validation	2018/01/01	English	267
Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: Findings from a systematic review of the published literature, 1999–2009	2011/10/01	English	265
A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy	2013/09/01	English	265
A systematic review of factors affecting vaccine uptake in young children	2017/10/01	English	263
Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies	2014/06/01	English	258
Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data	2016/12/01	English	255
Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies	2007/05/01	English	253
Updating the Natural History of Human Papillomavirus and Anogenital Cancers	2012/11/01	English	253
Meningococcal carriage and disease—Population biology and evolution	2009/06/01	English	250
Hepatitis B virus genotypes	2005/03/01	English	247
Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity	2019/05/01	English	246
The 5As: A practical taxonomy for the determinants of vaccine uptake	2016/02/01	English	246